Is AKRO undervalued or overvalued?
As of 2025-03-25, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is -14.90 USD. This AKRO valuation is based on the model Peter Lynch Fair Value. With the current market price of 45.08 USD, the upside of Akero Therapeutics Inc is -133.05%. This means that AKRO is overvalued by 133.05%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -14.90 - -14.90 | -14.90 | -133.05% |
| DDM - Stable | (22.49) - (73.33) | (47.91) | -206.3% |
| DDM - Multi | (0.24) - (0.58) | (0.33) | -100.7% |
| Market Cap (mil) | 3,589.27 |
| Beta | 0.65 |
| Outstanding shares (mil) | 79.62 |
| Enterprise Value (mil) | 3,589.27 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.47% |
| Cost of Debt | 5.00% |
| WACC | 10.42% |